Home › Cardiomyopathy › Illinois
Cardiomyopathy clinical trials in Illinois
5 studies for Cardiomyopathy are looking for participants at sites in Illinois.
Cities in Illinois
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Clinical Trial Site, Chicago
- Clinical Trial Site, Evanston
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Sep 16, 2026 · NCT07052903Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- John H. Stroger, Jr. Hospital of Cook County, Chicago
- University of Chicago - Medical Center, Chicago
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 4, 2026 · NCT06563895Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials
- Lurie Children's, Chicago
RecruitingObservational study
All ages · All sexes · Updated Jul 28, 2026 · NCT07674758MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- Northwestern University, Chicago
RecruitingPhase 3
Ages 18 to 90 · All sexes · Updated Mar 27, 2026 · NCT06128629Genetics of Cardiovascular and Neuromuscular Disease
- University of Chicago, Chicago
RecruitingObservational study
All ages · All sexes · Updated Sep 9, 2025 · NCT00138931From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.